BIOMAT Database Logo BIOMAT Database Logo

Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). 1993

P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710.

Remifentanil is a newly synthesized 4-anilido-piperidine with an ester side chain susceptible to esterase metabolism. We evaluated the safety, analgesic efficacy, and pharmacokinetics of remifentanil in 48 male volunteers. Volunteers were randomized to receive increasing doses of remifentanil, alfentanil, or placebo. Analgesic efficacy was evaluated by increasing tolerance to a spring-loaded rod measured at the tibia and sternum at multiple time points. Respiratory depression was measured by changes in arterial blood gas tensions and peripheral hemoglobin oxygen saturation. Hemodynamics were continuously monitored by means of an intra-arterial catheter. Both remifentanil and alfentanil produced a dose-dependent increase in analgesia and respiratory depression. Remifentanil was 20 to 30 times more potent (milligram to milligram) than alfentanil when assessed by either analgesic efficacy or respiratory measures. The pharmacokinetics of remifentanil were best described by a biexponential decay curve. Remifentanil had a small volume of distribution of 0.39 (SD, +/- 0.25) L/kg (alfentanil, 0.52 +/- 2 L/kg), with a rapid distribution phase of 0.94 (SD, +/- 0.57) min and an extremely short elimination half-life of 9.5 (SD, +/- 4) min compared with an elimination half-life of alfentanil of 58 (SD, +/- 7.6) min. The t1/2 ke0 (half-time for equilibration between plasma and the effect compartment) of remifentanil for analgesia was calculated as 1.3 min. Thus, remifentanil appears to have a pharmacologic profile similar to other potent mu agonists, but with exceptionally short-lasting pharmacokinetics, which is likely to make it a very useful opioid for clinical practice.

UI MeSH Term Description Entries
D008297 Male Males
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D010880 Piperidines A family of hexahydropyridines.
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077208 Remifentanil A piperidine-propionate derivative and opioid analgesic structurally related to FENTANYL. It functions as a short-acting MU OPIOID RECEPTOR agonist, and is used as an analgesic during induction or maintenance of general anesthesia, following surgery, during childbirth, and in mechanically ventilated patients under intensive care. 3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester,GI 87084B,GI-87084B,GI87084B,Remifentanil Hydrochloride,Remifentanil Monohydrochloride,Ultiva
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid
D012449 Safety Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property. Safeties

Related Publications

P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
[Remifentanil--ultra-short acting opioid and its possible applications in anesthesiology].
January 2005, Wiadomosci lekarskie (Warsaw, Poland : 1960),
P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal.
August 1995, Clinical pharmacokinetics,
P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
Remifentanil: a novel, short-acting, mu-opioid.
September 1996, Anesthesia and analgesia,
P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation.
April 2024, Pharmaceutics,
P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
Pain management in intensive care unit patients: the role of ultra-short acting opioid: remifentanil.
January 2013, Anesthesiology and pain medicine,
P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
An Allometric Model of Remifentanil Pharmacokinetics and Pharmacodynamics.
June 2017, Anesthesiology,
P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker.
January 2005, Drugs in R&D,
P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats.
May 2000, Psychopharmacology,
P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.
November 1993, Anesthesiology,
P S Glass, and D Hardman, and Y Kamiyama, and T J Quill, and G Marton, and K H Donn, and C M Grosse, and D Hermann
Determination of remifentanil, an ultra-short-acting opioid anesthetic, in rat blood by high performance liquid chromatography with ultraviolet detection.
September 1996, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!